학술논문

Once-Weekly Efanesoctocog Alfa Prophylaxis Provided High Sustained Factor VIII Activity Levels, Independent of Blood Group, in Children <12 Years of Age with Severe Hemophilia A
Document Type
Journal
Source
BLOOD; NOV 2 2023, 142 3p. Supplement: 1
Subject
Language
English
ISSN
15280020